Txcell
Records under this name other than patents Txcell holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Txcell
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,977,093 | Obtention of Food- or Auto-Antigen Specific TR1 Cells from a Leukocyte or PBMC Population Lapsed on the fee record Ended Jul 12, 2023 · High confidence | Lapsed on the fee record | Ended Jul 12, 2023 | High confidence |
| US 8,992,907 | Compositions for treating an intestinal inflammatory condition Lapsed on the fee record Ended Mar 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 31, 2023 | From the USPTO record |
| US 7,771,932 | Method for identification of Tr1 lymphocytes regulators by the presence and over-expression of specific molecules and application thereof Lapsed on the fee record Ended Aug 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2022 | From the USPTO record |
| US 9,517,253 | Compositions for treating multiple sclerosis Lapsed on the fee record Ended Dec 13, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2020 | From the USPTO record |
| US 8,815,534 | Method for assessing the efficacy of a TR1 cell therapy in a subject Lapsed on the fee record Ended Aug 26, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 26, 2018 | From the USPTO record |
| US 8,722,401 | In Vitro Production of a Cell Population Using Feeder Cells Formerly held Lapsed on the fee record Ended May 13, 2018 · High confidence | Lapsed on the fee record | Ended May 13, 2018 | High confidence |
| US 7,985,409 | TR1 Cells for Use in Atherosclerosis Lapsed on the fee record Ended Jul 26, 2015 · High confidence | Lapsed on the fee record | Ended Jul 26, 2015 | High confidence |